This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Nature cancer · 2026
Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings.
Transplantation and cellular therapy · 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.
Current oncology (Toronto, Ont.) · 2026 · senior author
Latest funding
- $2,796,075
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
CIHR · 2023 · Principal investigator
6 publications.
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Zemp FJ, Breckenridge Z, Song H, Gill GS, Louie TL, Narta K, Liu H, Suh Y, Guignard L, Mandujano-Tinoco EA, Collao N, Pyczek J, Ellestad KK, Curry J, Langley J, John C, Mah LK, Rajwani J, Evseev D, Turk M, Benaoudia S, Alex J, Naumenko V, Manoharan VT, Mehrabadi MK, Smith HA, Gilbert GNY, Gillmor A, Verhey TB, Todesco HM, Osz K, Ahn BY, Bogossian A, Anderson C, Sikdar S, Rukunuddin S, Bismar TA, Heng DYC, Lawson K, Linehan WM, Pedersen H, Gordon PMK, McIntyre JB, MacGregor J, Garzia L, Brodeur-Robb K, DiFrancesco L, Ogilvie T, Schöffski P, Wozniak A, Holt RA, Bell J, Senger DL, Lewis V, Monument M, Khan O, Baudrier L, Billon P, Gabriel V, Biernaskie J, Potts K, Trpkov K, Hay K, Quizi J, Chan J, Saleh R, Henning JW, Prokopishyn NL, Shafey M, Morrissy AS, Mahoney DJ
Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings.
O'Sullivan DE, Blosser N, Crisp N, Randhawa B, Bista S, Beda G, Shafey M, Hay K, Puckrin R, Daly A, Storek J, Jamani K
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.
Lemieux C, Kuruvilla J, Shafey M, Davison K, Paulson K, Li SZL, Billen L, Nissen F, Wang HL, Kim JJ, Lee G, Hu ZH, Logan B, Feng Z, Pasquini MC, Hay K
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database
Kaedbey R, Venner CP, Reece D, Hay K, Gul E, Su J, McCurdy A, Chu MP, Jimenez-Zepeda VH, Song K
Time spent in healthcare among older patients with primary central nervous system lymphoma treated with high-dose methotrexate.
Stewart C, Owen C, Street L, Hay K, Perry S, Duggan P, Shafey M, Balogh A, Cao J, Chua N, Stewart D, Puckrin R
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.
Seftel MD, Musto G, Allan D, Bucher O, Hay K, Pasic I, Truong T, Paulson K
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
Principal investigators: Shafey, Mona; Abdul Razak, Albiruni R; Hay, Kevin A; Henning, Jan-Willem; Kekre, Natasha; Mahoney, Douglas J; Morrissy, Sorana A; Noujaim, Jonathan; Simmons, Christine E
Keywords: Alveolar Soft Part Sarcoma; Car T; Immunotherapy; Renal Cell Carcinoma; Sarcoma; Triple-Negative Breast Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Department of Medicine
- Oncology
- Pathology and Laboratory Medicine
- Biochemistry, Microbiology and Immunology
- Department of Epidemiology and Biostatistics
- Surgery
- Other
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Mona Shafey
Medicine
4 shared papers, latest 2026
Pierre Billon
Biochemistry and Molecular Biology
1 shared papers, latest 2026
Arleigh McCurdy
Department of Medicine
1 shared papers, latest 2026
David Allan
Department of Medicine
1 shared papers, latest 2024
Martha Louzada
Department of Epidemiology and Biostatistics
1 shared papers, latest 2026
John Bell
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2026
Michael Sebag
Medicine
1 shared papers, latest 2026
Jennifer Chan
Pathology and Laboratory Medicine
1 shared papers, latest 2026
Donna Reece
Faculty
1 shared papers, latest 2026
Michael Monument
Surgery
1 shared papers, latest 2026
Hira Mian
Oncology
1 shared papers, latest 2026
John Kuruvilla
Faculty
1 shared papers, latest 2026
Ramy Saleh
Medicine
1 shared papers, latest 2026
Jennifer Quizi
Faculty
1 shared papers, latest 2026
Victor Lewis
Pediatrics
1 shared papers, latest 2026
Livia Garzia
Faculty
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.